{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:25:26Z","timestamp":1770740726361,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq; from Brazil)"},{"name":"Ministry of Health\/Secretariat of Health Surveillance\/National STD and AIDS Programme (MOH\/SHS\/NAP)"},{"name":"FIPE-Hospital de Clinicas de Porto Alegre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-2377-3","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T09:57:32Z","timestamp":1484301452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study"],"prefix":"10.1186","volume":"10","author":[{"given":"Paulo R.","family":"Alencastro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nemora T.","family":"Barcellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando H.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Let\u00edcia R.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Schuelter-Trevisol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aj\u00e1cio B. M.","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6351-9588","authenticated-orcid":false,"given":"Sandra C.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","volume":"173","author":"MS Freiberg","year":"2013","unstructured":"Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614\u201322.","journal-title":"JAMA Intern Med"},{"key":"2377_CR2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s40265-013-0108-1","volume":"73","author":"G Guaraldi","year":"2013","unstructured":"Guaraldi G, Stentarelli C, Zona S, Santoro A. A HIV-associated lipodystrophy: impact of antiretroviral therapy. Drugs. 2013;73:1431\u201350.","journal-title":"Drugs"},{"key":"2377_CR3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1610-0387.2009.07330_supp.x","volume":"8","author":"A Potthoff","year":"2010","unstructured":"Potthoff A, Brocmeyer NH, Gelbrich G, Neuhaus K, Stefa E, Reinsch N. Lipodystrophy\u2014a sign for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges. 2010;8:92\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"key":"2377_CR4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.qai.0000243052.73321.8e","volume":"43","author":"T Brown","year":"2006","unstructured":"Brown T, Wang Z, Chu H, Palela FJ, Kingsley L, Witt MD, et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2006;43:356\u201362.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/aid.2012.0214","volume":"29","author":"P Leclercq","year":"2013","unstructured":"Leclercq P, Dr Goujard CM, Duracinsky M, Allaert F, L\u2019henaff M, Hellet M, et al. High prevalence and impact on the quality of life of facial lipoatrophy and other abnormalities in fat tissue distribution in HIV-infected patients treated with antiretroviral therapy. AIDS Res Hum Retroviruses. 2013;29:761\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2377_CR6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","volume":"34","author":"M Sav\u00e8s","year":"2002","unstructured":"Sav\u00e8s M, Raffi F, Capeau J, Rozenbaum W, Ragnaud JM, Perronne C, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002;34:1396\u2013405.","journal-title":"Clin Infect Dis"},{"key":"2377_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jocd.2010.01.005","volume":"13","author":"P Freitas","year":"2010","unstructured":"Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E, et al. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral therapy. J Clin Densitom. 2010;13:197\u2013203.","journal-title":"J Clin Densitom"},{"key":"2377_CR8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/QAI.0b013e31819c16f4","volume":"51","author":"S Mercier","year":"2009","unstructured":"Mercier S, Gueye NF, Cournil A, Fontbonne A, Copin N, Ndiaye I, et al. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case\u2013control study. J Acquir Immune Defic Syndr. 2009;51:224\u201330.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case\u2013control study. Lancet. 2003;361:726\u201335.","journal-title":"Lancet"},{"key":"2377_CR10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/09540121.2010.543885","volume":"23","author":"JE Lake","year":"2011","unstructured":"Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, et al. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011;23:929\u201338.","journal-title":"AIDS Care"},{"key":"2377_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","volume":"40","author":"P Bacchetti","year":"2005","unstructured":"Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr. 2005;40:121\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/apc.2013.0294","volume":"28","author":"J Jantarapakde","year":"2014","unstructured":"Jantarapakde J, Phanuphak N, Chaturawit C, Pengnonyang S, Mathajittiphan P, Takamtha P, et al. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults. AIDS Patient Care STDS. 2014;28:331\u201340.","journal-title":"AIDS Patient Care STDS"},{"key":"2377_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","volume":"14","author":"T Saint-Marc","year":"2000","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS. 2000;14:37\u201349.","journal-title":"AIDS"},{"key":"2377_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/135965350300800511","volume":"8","author":"JP Ioannidis","year":"2003","unstructured":"Ioannidis JP, Trikalinos TA, Law M, Carr A, HIV Lipodystrophy Case Definition Study Group. HIV lipodystrophy case definition using artificial neural network modelling. Antivir Ther. 2003;8:435\u201341.","journal-title":"Antivir Ther"},{"key":"2377_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/apc.2009.0191","volume":"24","author":"E Cabrero","year":"2010","unstructured":"Cabrero E, Griffa L, Burgos A, HIV Body Physical Changes Study Group. Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions. AIDS Patient Care STDS. 2010;24:5\u201313.","journal-title":"AIDS Patient Care STDS"},{"key":"2377_CR16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","volume":"30","author":"KV Heath","year":"2002","unstructured":"Heath KV, Hogg RS, Singer J, Chan KJ, O\u2019Shaughnessy MV, Montaner JS. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort. J Acquir Immune Defic Syndr. 2002;30:440\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e318158c0a6","volume":"46","author":"E Mutimura","year":"2007","unstructured":"Mutimura E, Stewart A, Rheeder P, Crowther NJ. Metabolic function and the prevalence of lipodystrophy in a population of HIV-infected African subjects receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46:451\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ Jr, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389\u201398.","journal-title":"AIDS"},{"key":"2377_CR19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/381684","volume":"38","author":"FJ Palella Jr","year":"2004","unstructured":"Palella FJ Jr, Cole SR, Chmiel JS, Riddler SA, Visscher B, Dobs A, et al. Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis. 2004;38:903\u20137.","journal-title":"Clin Infect Dis"},{"key":"2377_CR20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00007435-200302000-00014","volume":"30","author":"NT Barcellos","year":"2003","unstructured":"Barcellos NT, Fuchs SC, Fuchs FD. Prevalence of and risk factors for HIV infection in individuals testing for HIV at counseling centers in Brazil. Sex Transm Dis. 2003;30:166\u201373.","journal-title":"Sex Transm Dis"},{"key":"2377_CR21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093\u20139.","journal-title":"Lancet"},{"key":"2377_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001432-200402000-00005","volume":"17","author":"PC Tien","year":"2004","unstructured":"Tien PC, Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis. 2004;17:27\u201332.","journal-title":"Curr Opin Infect Dis"},{"key":"2377_CR23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366:1059\u201362.","journal-title":"Lancet"},{"key":"2377_CR24","first-page":"805","volume-title":"Nutrition therapy and pathophysiology","author":"C Fields-Gardner","year":"2007","unstructured":"Fields-Gardner C. HIV and AIDS. In: Nelms M, Sucher K, Long S, editors. Nutrition therapy and pathophysiology. Belmont: Thomson\/Brooks-Cole; 2007. p. 805\u201342."},{"key":"2377_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.aids.0000191485.92285.c7","volume":"19","author":"CP Santos","year":"2005","unstructured":"Santos CP, Felipe YX, Braga PE, Ramos D, Lima RO, Segurado AC. Self-perception of body changes in persons living with HIV\/AIDS: prevalence and associated factors. AIDS. 2005;19:14\u201321.","journal-title":"AIDS"},{"key":"2377_CR26","first-page":"402638","volume":"2015","author":"SO Iwuala","year":"2015","unstructured":"Iwuala SO, Lesi OA, Fasanmade OA, Sabir AA, Olamoyegun MA, Okany CC. Prevalence of and risk factors for lipoatrophy in patients with HIV infection in Nigeria. AIDS Res Treat. 2015;2015:402638.","journal-title":"AIDS Res Treat"},{"key":"2377_CR27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/aje\/kwj111","volume":"163","author":"PC Tien","year":"2006","unstructured":"Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C. The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol. 2006;163:860\u20139.","journal-title":"Am J Epidemiol"},{"key":"2377_CR28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00126334-200312150-00003","volume":"34","author":"PC Tien","year":"2003","unstructured":"Tien PC, Cole SR, Williams CM, Li R, Justman JE, Cohen MH, et al. Incidence of lipoatrophy and lipohypertrophy in the women\u2019s interagency HIV study. J Acquir Immune Defic Syndr. 2003;34:461\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2377_CR29","doi-asserted-by":"crossref","first-page":"e63623","DOI":"10.1371\/journal.pone.0063623","volume":"8","author":"R Waal de","year":"2013","unstructured":"de Waal R, Cohen K, Maartens G. Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction. PLoS ONE. 2013;8:e63623.","journal-title":"PLoS ONE"},{"key":"2377_CR30","doi-asserted-by":"crossref","first-page":"19033","DOI":"10.7448\/IAS.18.1.19033","volume":"18","author":"JL Finkelstein","year":"2015","unstructured":"Finkelstein JL, Gala P, Rochford R, Glesby MJ, Mehta S. HIV\/AIDS and lipodystrophy: implications for clinical management in resource-limited settings. J Int AIDS Soc. 2015;18:19033.","journal-title":"J Int AIDS Soc"},{"key":"2377_CR31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","volume":"17","author":"PW Mallon","year":"2003","unstructured":"Mallon PW, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS. 2003;17:971\u20139.","journal-title":"AIDS."}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2377-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T15:49:38Z","timestamp":1658418578000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2377-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2377-3","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"article-number":"40"}}